Radiation therapy firm North American Scientific (NAS) said that its Nomos radiation oncology division has received U.S. Food and Drug Administration 510(k) clearance for its nomosStat serial tomotherapy automated treatment offering.
The Chatsworth, CA-based firm first introduced nomosStat at the American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in October 2005.
By AuntMinnie.com staff writers
July 25, 2006
Related Reading
NAS back in compliance with Nasdaq, June 29, 2006
NAS revenues dip in Q2, June 8, 2006
NAS raises $24 million, June 7, 2006
NAS inks prostate brachytherapy deal with Novation, May 18, 2006
U.S. NRC signs off on NAS brachytherapy, May 8, 2006
Copyright © 2006 AuntMinnie.com
